CD8A and neoplasm: To further verify this conclusion, T-cell-mediated tumour cell-killing assays were performed to test the impact of B4GALT1 expression on CD8 + T-cell activity, which were isolated from the peripheral blood of healthy donors and the spleens of C57BL/6 mice (Fig. 4G).